Changping Wu
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 30
- Cancer Immunotherapy and Biomarkers 14
- Inflammatory Biomarkers in Disease Prognosis 6
- Peptidase Inhibition and Analysis 5
- Colorectal Cancer Treatments and Studies 5
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 9
Changping Wu
58 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 102
- Oncology 1.3k
- Hepatology 318
- Cancer Research 599
- Immunology 619
- Pulmonary and Respiratory Medicine 508
Countries citing papers authored by Changping Wu
This map shows the geographic impact of Changping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changping Wu more than expected).
Fields of papers citing papers by Changping Wu
This network shows the impact of papers produced by Changping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changping Wu. The network helps show where Changping Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Changping Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 67 | |
| 4 | 2020 | 11 | |
| 5 | 2019 | 23 | |
| 6 | 2018 | 52 | |
| 7 | 2018 | 15 | |
| 8 | 2018 | 17 | |
| 9 | 2018 | 47 | |
| 10 | 2018 | 27 | |
| 11 | 2017 | 9 | |
| 12 | 2016 | 244 | |
| 13 | 2016 | 6 | |
| 14 | 2016 | 187 | |
| 15 | 2016 | 8 | |
| 16 | 2015 | 199 | |
| 17 | 2014 | 43 | |
| 18 | 2014 | 1 | |
| 19 | 2012 | 8 | |
| 20 | 2011 | 81 |
About Changping Wu
Changping Wu is a scholar working on Oncology, Cancer Research, Immunology, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 58 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Immune Cell Function and Interaction (13 papers), MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (9 papers), Gastric Cancer Management and Outcomes (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Peptidase Inhibition and Analysis (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Oncology (1.3k citations), Hepatology (318 citations), Cancer Research (599 citations), Immunology (619 citations) and Pulmonary and Respiratory Medicine (508 citations). Changping Wu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Jingting Jiang, Xiao Zheng, Bin Xu, Yiting Geng, Lujun Chen, Yingjie Shao, Yanjie Xu, Danxia Zhu, Wenting He and Wenwei Hu. Their work appears in journals such as Medicine, Cellular Physiology and Biochemistry, Oncotarget, Oncology Reports and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.